Business Context and Reporting Period
Company: Inogen, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 11, 2021
Event: Regulation FD Disclosure regarding participation in the 2021 J.P. Morgan Healthcare Conference.
Key Financial Metrics
This filing does not contain audited financial statements, revenue, profit, cash flow, margin, debt, or liquidity figures. The only specific operational metric disclosed is an updated inside sales representative headcount of 300 as of December 31, 2020.
Material Changes
No material financial changes versus prior periods are reported in this document. The filing serves to disclose an upcoming investor presentation and an update to sales headcount figures included in that presentation.
Guidance, Outlook, and Management Commentary
- Conference Participation: The CEO and CFO are scheduled to present at the 2021 J.P. Morgan Healthcare Conference on January 12, 2021, at 2:20 p.m. PT.
- Updated Presentation: The company will utilize an updated slide presentation (Exhibit 99.1) during the conference and analyst sessions.
- Operational Update: The updated presentation reflects an inside sales representative headcount of 300 as of December 31, 2020.
- Access: A live audio webcast is available via the Investor Relations section of the company website.
Investor Verification Checklist
- Verify the content of the updated investor presentation (Exhibit 99.1) attached to this filing.
- Confirm the accuracy of the inside sales headcount figure (300) as of December 31, 2020.
- Review the live webcast or transcript of the January 12, 2021, presentation for forward-looking statements and guidance.
- Note that the information in this 8-K and its exhibits is not deemed "filed" under Section 18 of the Exchange Act.